BC Platforms Partners with Australian Tissue Bank (ABCTB) to Improve Breast Cancer Treatment Outcomes

Read full release

Vaccitech Doses First Patient in HPV001, a Phase 1/2 Clinical Trial of VTP-200 Immunotherapeutic for High-risk Persistent HPV Infection

Read full release

Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

Read full release

Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein degradation assets

Read full release

TILT Biotherapeutics advances cancer immunotherapy clinical trial achieving primary end point in the first cohort

Read full release

Valo Therapeutics and ImmunoScape Collaboration Identifies Immunogenic Peptides to Develop Pan Coronavirus Vaccine

Read full release

Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline

Read full release

Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP-300 Immunotherapeutic Candidate for Chronic HBV Patients

Read full release

BC Platforms, RIKEN and the Finnish Institute for Health and Welfare (THL) collaborate on artificial intelligence approach to identify people most at risk of from COVID-19

Read full release

Pneumagen Announces £2.5m fundraising to advance universal treatment for viral respiratory infections into the clinic this year

Read full release

InVixa announces licensing deal with University of California, Davis for the commercialization of novel inhaled statins for the treatment of COVID-19

Read full release

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies

Read full release

Oxford University and Vaccitech welcome UK regulatory emergency use authorisation of coronavirus vaccine

Read full release

BC Platforms delivers data platform for UK research consortium to improve detection of lung cancer

Read full release

BC Platforms Rings in an Award-Winning Year with record growth in its BCRQUEST.com global data partner network and BC|INSIGHT Discovery and Research platform

Read full release

BC Platforms Announces Partnership with CO-CONNECT Consortium to accelerate COVID-19 research

Read full release

BC Platforms Announces Colorado Center for Personalized Medicine Joins Global Data Partner Network BCRQUEST.com to advance Personalized Healthcare Research

Read full release

Theolytics Announces Appointment of Immatics’ Carsten Reinhardt to its Board of Directors

Read full release

First participant dosed in Phase 1 clinical study with VTP-300 immunotherapeutic to treat chronically infected Hepatitis B patients

Read full release

TILT Biotherapeutics secures over EUR 6 million to advance cancer immunotherapies into clinic

Read full release

IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford

Read full release

BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration

Read full release

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate

Read full release

Pneumagen Ltd Announces Positive Anti–Viral Activity for Novel Glycan Approach in Preventing COVID–19 Infections

Read full release

Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology

Read full release

World’s leading biobanks join BC Platforms’ Global Data Partner Network to advance personalized healthcare research

Read full release

Valo Therapeutics Receives Prize at the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Awards

Read full release

BC Platforms partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers

Read full release

BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics

Read full release

Pneumagen Presents Poster on Multivalent Sialic Acid-binding Proteins as a Novel Preventative and Treatment of RSV at RSVVW 2019

Read full release

IRBM signs agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies.

Read full release

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

Read full release

Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein degradation assets

Read full release

BC Platforms Partners with Australian Tissue Bank (ABCTB) to Improve Breast Cancer Treatment Outcomes

Read full release

BC Platforms, RIKEN and the Finnish Institute for Health and Welfare (THL) collaborate on artificial intelligence approach to identify people most at risk of from COVID-19

Read full release

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies

Read full release

BC Platforms delivers data platform for UK research consortium to improve detection of lung cancer

Read full release

BC Platforms Rings in an Award-Winning Year with record growth in its BCRQUEST.com global data partner network and BC|INSIGHT Discovery and Research platform

Read full release

BC Platforms Announces Partnership with CO-CONNECT Consortium to accelerate COVID-19 research

Read full release

BC Platforms Announces Colorado Center for Personalized Medicine Joins Global Data Partner Network BCRQUEST.com to advance Personalized Healthcare Research

Read full release

BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration

Read full release

World’s leading biobanks join BC Platforms’ Global Data Partner Network to advance personalized healthcare research

Read full release

BC Platforms partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers

Read full release

BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics

Read full release

IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford

Read full release

IRBM signs agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies.

Read full release

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

Read full release

Pneumagen Announces £2.5m fundraising to advance universal treatment for viral respiratory infections into the clinic this year

Read full release

Pneumagen Ltd Announces Positive Anti–Viral Activity for Novel Glycan Approach in Preventing COVID–19 Infections

Read full release

Pneumagen Presents Poster on Multivalent Sialic Acid-binding Proteins as a Novel Preventative and Treatment of RSV at RSVVW 2019

Read full release

Vaccitech Doses First Patient in HPV001, a Phase 1/2 Clinical Trial of VTP-200 Immunotherapeutic for High-risk Persistent HPV Infection

Read full release

Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

Read full release

Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP-300 Immunotherapeutic Candidate for Chronic HBV Patients

Read full release

Oxford University and Vaccitech welcome UK regulatory emergency use authorisation of coronavirus vaccine

Read full release

First participant dosed in Phase 1 clinical study with VTP-300 immunotherapeutic to treat chronically infected Hepatitis B patients

Read full release

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate

Read full release

Valo Therapeutics and ImmunoScape Collaboration Identifies Immunogenic Peptides to Develop Pan Coronavirus Vaccine

Read full release

Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology

Read full release

Valo Therapeutics Receives Prize at the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Awards

Read full release

TILT Biotherapeutics advances cancer immunotherapy clinical trial achieving primary end point in the first cohort

Read full release

TILT Biotherapeutics secures over EUR 6 million to advance cancer immunotherapies into clinic

Read full release